Search alternatives:
point decrease » point increase (Expand Search)
nm decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
nm decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
1441
-
1442
<i>SLC2A2</i> is essential for liver differentiation in developing vertebrates
Published 2025“…Total RNA was isolated from uninjected control and <i>SLC2A2</i> MO‐injected embryos (2.5, 5, and 10 ng). …”
-
1443
-
1444
Molecular model of bio-oil rejuvenator 0f BR-5.
Published 2025“…A blend model was developed for virgin asphalt binder and aged asphalt binder with rejuvenator system, which is saturated with 12 different molecules. …”
-
1445
-
1446
-
1447
-
1448
-
1449
-
1450
-
1451
-
1452
-
1453
-
1454
-
1455
Doctors’ perceptions of the impact of upfront point-of-care testing in the emergency department
Published 2018“…Upfront, protocolised, POC testing is a low-input, high-yield intervention that decreased treatment time and satisfied doctors.…”
-
1456
-
1457
-
1458
HbA1c, lipid profiles and risk of incident type 2 Diabetes in United States Veterans
Published 2018“…Compared to normoglycemic Veterans (HbA1c: 5.0–5.6%; 31–38 mmol/mol), risks for diabetes were >2-fold in the moderate prediabetes risk group (HbA1c: 5.7–5.9%; 39–41 mmol/mol) (HR 2.37 [1.98–2.85]) and >5-fold in the high risk prediabetes group (HbA1c: 6.0–6.4%; 42–46 mmol/mol) (HR 5.59 [4.75–6.58]). …”
-
1459
-
1460
a-c: Bone marrow (BM) EPO receptor (EPO-R) decreases in uremic anemia rats.
Published 2018“…<p>BM EPO-R protein (depicted as percentage of actin-corrected concentration) is unchanged in 7 day-bled rats Vs controls (Fig. 4a). Contrary to that BM EPO-R protein decreases in uremic (4 weeks after 5/6 nephrectomy) rats (Fig. 4b). …”